| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Acetyl-L-Carnitine | Alzheimer's Disease | 6 | PM | 36988119 | 📋 | A comparative study of acetyl-l-carnitine and caloric restriction impact on hippocampal autophagy, apoptosis, neurogenesis, and astroglial function in AlCl3-induced Alzheimer's in rats |
| Acetyl-L-Carnitine | Alzheimer's Disease | 5 | PM | 34886786 | 📋 | Ameliorative effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in mouse model |
| Acetyl-L-Carnitine | Alzheimer's Disease | 4 | PM | 34164711 | 📋 | Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model |
| Acetyl-L-Carnitine | Alzheimer's Disease | 10 | PM | 22027664 | 📋 | [Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia] |
| Acetyl-L-Carnitine | Alzheimer's Disease | 9 | PM | 21978079 | 📋 | Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities |
| Acetyl-L-Carnitine | Alzheimer's Disease | 7 | PM | 21939756 | 📋 | Natural substances and Alzheimer's disease: from preclinical studies to evidence based medicine |
| Acetyl-L-Carnitine | Alzheimer's Disease | 8 | PM | 21689104 | 📋 | Acetyl-L-carnitine ameliorates spatial memory deficits induced by inhibition of phosphoinositol-3 kinase and protein kinase C |
| Acetyl-L-Carnitine | Alzheimer's Disease | 3 | PM | 21183322 | 📋 | Modulatory Effects of Vitamin E, acetyl-L-carnitine and α-Lipoic Acid on New Potential Biomarkers for Alzheimer's Disease in Rat Model |
| Acetyl-L-Carnitine | Alzheimer's Disease | 11 | PM | 20110616 | 📋 | Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats |
| Acetyl-L-Carnitine | Alzheimer's Disease | 2 | PM | 18846423 | 📋 | Mitochondrial Decay in the Brains of Old Rats: Ameliorating Effect of Alpha-Lipoic Acid and acetyl-L-carnitine |
| Acetyl-L-Carnitine | Alzheimer's Disease | 1 | PM | 1944900 | 📋 | Long-term acetyl-L-carnitine Treatment in Alzheimer's Disease |
| Acetyl-L-Carnitine | Amyotrophic Lateral Sclerosis | 1 | PM | 36998125 | 📋 | Acetyl-L-carnitine and Amyotrophic Lateral Sclerosis: current evidence and potential use |
| Acetyl-L-Carnitine | Amyotrophic Lateral Sclerosis | 2 | PM | 23421600 | 📋 | Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS |
| Acetyl-L-Carnitine | Demyelinating Disease | 1 | PM | 35912879 | 📋 | Ameliorative Effects of Acetyl-L-Carnitine on Corpus Callosum and Functional Recovery in Demyelinated Mouse Model |
| Acetyl-L-Carnitine | Demyelinating Disease | 2 | PM | 28583580 | 📋 | Acetyl-l-carnitine enhances myelination of regenerated fibers of the lateral olfactory tract |
| Acetyl-L-Carnitine | Demyelinating Disease | 3 | PM | 21614517 | 📋 | Modulation of myelin basic protein gene expression by acetyl-L-carnitine |
| Acetyl-L-Carnitine | Multiple Sclerosis | 2 | PM | 35912879 | 📋 | Ameliorative Effects of Acetyl-L-Carnitine on Corpus Callosum and Functional Recovery in Demyelinated Mouse Model |
| Acetyl-L-Carnitine | Multiple Sclerosis | 1 | PM | 29864912 | 📋 | The possible anti-apoptotic and antioxidant effects of acetyl l-carnitine as an add-on therapy on a relapsing-remitting model of experimental autoimmune encephalomyelitis in rats |
| Acetyl-L-Carnitine | Neurodegenerative Disease | 1 | PM | 27975173 | 📋 | Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats |
| Acetyl-L-Carnitine | Neurodegenerative Disease | 2 | PM | 26223802 | 📋 | ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats |
| Acetyl-L-Carnitine | Parkinson's Disease | 1 | PM | 30890473 | 📋 | Neuroprotective effects of acetyl-l-carnitine (ALC) in a chronic MPTP-induced Parkinson's disease mouse model: Endothelial and microglial effects |
| Acetyl-L-Carnitine | Parkinson's Disease | 4 | PM | 28577987 | 📋 | ALCAR promote adult hippocampal neurogenesis by regulating cell-survival and cell death-related signals in rat model of Parkinson's disease like-phenotypes |
| Acetyl-L-Carnitine | Parkinson's Disease | 3 | PM | 28199883 | 📋 | Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson's disease in the rat |
| Acetyl-L-Carnitine | Parkinson's Disease | 2 | PM | 27975173 | 📋 | Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats |
| Acetyl-L-Carnitine | Parkinson's Disease | 6 | PM | 26223802 | 📋 | ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats |
| Acetyl-L-Carnitine | Parkinson's Disease | 5 | PM | 21958946 | 📋 | Acetyl-L-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy |
| Acetyl-L-Carnitine | Parkinson's Disease | 7 | PM | 20414966 | 📋 | Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease |
